Position in ALNY
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$4,547,660
-$3,220,174 QoQ
Shares Held
15,107
-35.7% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#247
of 780 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026OP Asset Management Ltd holds $55,880,193 across 21 Biotechnology names. ALNY ranks #3 (8.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
28,450 | $14,131,968 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
11,685 | $7,286,064 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
15,107 | $4,547,660 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
22,941 | $4,296,390 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
56,060 | $3,207,753 | |
| 6 | KURA |
Kura Oncology, Inc.
|
291,880 | $3,201,923 | |
| 7 | RARE |
Ultragenyx Pharmaceutical Inc.
|
92,624 | $3,092,715 | |
| 8 | INSM |
INSMED Inc
|
24,951 | $2,660,275 |
All Filings in ALNY
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,547,660 | 15,107 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $7,767,834 | 23,477 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $5,873,290 | 14,770 | Shares | Sole | 2026-04-21 | |
| 2025-09-30 | $6,560,016 | 14,386 | Shares | Sole | 2026-04-20 | |
| 2025-06-30 | $4,543,738 | 13,934 | Shares | Sole | 2026-04-20 | |
| 2025-03-31 | $3,693,603 | 13,679 | Shares | Sole | 2026-04-20 | |
| No filing history on record for this holder in this stock. | ||||||